A New Device Eases One of the Most Annoying Parts of Routine Physicals

A Japanese medical device company, Nodoca, has developed an AI-powered tool that analyzes pharyngeal images to diagnose influenza and Covid-19. The device replaces uncomfortable nasal swabs and has been widely adopted across Japan's medical system.
Why it matters
It demonstrates the practical application of AI in medical diagnostics to improve patient comfort and diagnostic efficiency.
The system developed by Iris, Nodoca, uses AI to analyze images of the pharynx captured with a compact camera-equipped device, together with information from the patient's medical interview and other data, and returns an influenza assessment in a little over 10 seconds. It eliminates the need for the conventional test—one that is prone to causing discomfort because it requires inserting a swab deep into the nose to collect a nasal specimen—and can also be used at an earlier stage after symptom onset.
In 2022, it became the first AI-equipped medical device in Japan to receive approval as a “new medical device” and gain coverage under the national health insurance system. It has since been introduced at more than 2,000 medical institutions across Japan. In October 2025, it also received approval for an additional function related to Covid-19.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in